Circular No. 40/2024/TT-BYT stipulates the economic and technical characteristics of preventive healthcare services related to HIV/AIDS prevention and control at public healthcare facilities, issued by the Minister of Health.

MINISTRY OF HEALTH
____

SOCIALIST REPUBLIC OF VIET NAM
Independence - Freedom - Happiness
_________________________

Number: 40/2024/TT-BYT

        Hanoi, November 22, 2024

Place of Receipt:
- Social Committee of the National Assembly;
- Office of the Government (Department of Legal Affairs, Official Gazette, Government Portal);
- Minister (for reporting);
- Deputy Ministers of Health
- Ministry of Justice (Legal Normative Documents Inspection Department);
- Ministries, agencies equivalent to ministries, and government agencies;
- Provincial People's Councils and People's Committees under central jurisdiction;
- Units under the Ministry of Health;
- Health Departments of Ministries and sectors;
- Health Departments of provinces and centrally governed cities
- Central Health Stations of provinces and centrally-administered cities;
- Ministry of Health's Online Portal;
- To be filed: VT, AIDS, PC.

DEPUTY MINISTER
DEPUTY MINISTER

(Signed)

Nguyen Thi Lien Huong

No.

Detailed name

Specific type/Basic characteristics

I

Pre- and post-test counseling for HIV

1

Individual counseling at healthcare facilities

Pre-test counseling for HIV

2

Group counseling at healthcare facilities

3

Mobile individual counseling

4

Mobile group counseling

5

Remote individual counseling

6

Remote group counseling

7

Individual counseling at healthcare facilities

Post-test counseling for HIV including: post-screening counseling for HIV and post-confirmatory counseling for HIV

8

Group counseling at healthcare facilities

9

Mobile individual counseling

10

Mobile group counseling

11

Remote individual counseling

12

Remote group counseling

II

Counseling for high-risk individuals, those exposed to HIV, HIV-infected individuals, and AIDS patients

13

Individual counseling at healthcare facilities

Adherence counseling; Prevention of mother-to-child transmission of HIV counseling; Disclosure of HIV status to minors; Reproductive and sexual health care for minors; Transition of minors to adult treatment facilities; Medication use.

14

Group counseling at healthcare facilities

15

Mobile individual counseling

16

Mobile group counseling

17

Remote individual counseling

18

Remote group counseling

No.

Detailed name

Specific type/Basic characteristics

I

Examination for high-risk individuals, those exposed to HIV, HIV-infected individuals, and AIDS patients

1

Examination for high-risk individuals, those exposed to HIV, HIV-infected individuals, and AIDS patients at healthcare facilities

Examination for the following groups:

- High-risk individuals;

- Those exposed to HIV;

- HIV-infected individuals;

- AIDS patients.

2

Mobile examination for high-risk individuals, those exposed to HIV, HIV-infected individuals, and AIDS patients

3

Remote examination for high-risk individuals, those exposed to HIV, HIV-infected individuals, and AIDS patients

II

Determination of opioid addiction status

4

Clinical examination to determine opioid addiction status at healthcare facilities

Examination to determine opioid addiction status

5

Clinical examination to determine opioid addiction status outside healthcare facilities

6

Examination to determine opioid detoxification status at healthcare facilities

Examination to determine opioid detoxification status

7

Examination to determine opioid detoxification status outside healthcare facilities

III

Determination of stimulant addiction status (stimulant use disorder)

8

Clinical examination to determine stimulant addiction status at healthcare facilities

Examination to determine stimulant addiction status

9

Clinical examination to determine stimulant addiction status outside healthcare facilities

10

Examination to determine stimulant detoxification status at healthcare facilities

Examination to determine stimulant detoxification status

11

Examination to determine stimulant detoxification status outside healthcare facilities

IV

Determination of cannabis addiction status (cannabis use disorder)

12

Clinical examination to determine cannabis addiction status at healthcare facilities

Examination to determine cannabis addiction status

13

Clinical examination to determine cannabis addiction status outside healthcare facilities

14

Examination to determine cannabis detoxification status at healthcare facilities

Examination to determine cannabis detoxification status

15

Examination to determine cannabis detoxification status outside healthcare facilities

No.

Detailed name

Specific type/Basic characteristics

1

Rapid HIV Ab test

Diagnostic HIV testing and monitoring during HIV treatment including:

- Screening for HIV;

- Confirmatory HIV testing;

- Measuring HIV viral load;

- Early HIV infection diagnosis;

- Genotyping;

- CD4 cell count.

2

Rapid HIV Ag/Ab test

3

Semi-automatic HIV Ag/Ab immunoassay

4

Automatic HIV Ag/Ab immunoassay

5

Semi-automatic HIV Ab immunoassay

6

Automatic HIV Ab immunoassay

7

HIV agglutination test

8

HIV Western blot

9

Confirmatory HIV test

10

Automated HIV viral load measurement system

11

Real-time PCR HIV viral load measurement

12

HIV Xpert viral load measurement

13

HIV DNA PCR

14

Real-time PCR HIV DNA

15

Real-time PCR on dried blood spot samples

16

HIV genotyping by Sanger sequencing method for one gene

17

HIV genotyping by Next Generation Sequencing (NGS) method for one gene

18

HIV drug resistance genotyping

19

Quantitative CD4 count or CD4 cell count

20

HBsAg (HBsAg by chemiluminescence technique or rapid HBsAg test, or semi-automatic HBsAg immunoassay, or automatic HBsAg immunoassay)

Hepatitis B testing in HIV diagnosis and treatment

21

Anti-HCV (Anti-HCV by chemiluminescence technique, or rapid HCV Ab test, or semi-automatic HCV Ab immunoassay, or automatic HCV Ab immunoassay, or semi-automatic HCV Ag/Ab immunoassay, or automatic HCV Ag/Ab immunoassay)

Hepatitis C testing in HIV diagnosis and treatment

22

Syphilis (Treponema pallidum rapid test, or Treponema pallidum TPHA qualitative and quantitative, and Treponema pallidum RPR qualitative and quantitative, or Treponema pallidum PCR, or Treponema pallidum Real-time PCR)

Syphilis testing for HIV diagnosis and treatment

23

Gonorrhea (Neisseria gonorrhoeae staining microscopy, or Neisseria gonorrhoeae culture, identification and antibiotic susceptibility, or Neisseria gonorrhoeae PCR, or Neisseria gonorrhoeae Real-time PCR, or Neisseria gonorrhoeae Real-time PCR automated system)

Gonorrhea testing for HIV diagnosis and treatment

24

Chlamydia (Chlamydia rapid test, or Chlamydia Ab semi-automated immunoassay, or Chlamydia Ab fully automated immunoassay, or Chlamydia PCR, or Chlamydia Real-time PCR, or Chlamydia Real-time PCR automated system)

Chlamydia testing for HIV diagnosis and treatment

25

Complete peripheral blood cell analysis (by manual method, or by total counter, or by laser counter, or by fully automated system).

Blood formula test

26

Measurement of ALT activity (GPT)

Biochemical blood test

27

Measurement of AST activity (GOT)

28

Quantification of Creatinine (blood)

29

Quantification of Blood Urea [Blood]

30

Quantification of Blood Glucose

31

Electrolyte panel (Na, K, Cl) [Blood]

32

Quantification of Total Cholesterol (blood)

33

Quantification of HDL-C (High density lipoprotein Cholesterol) [Blood]

34

Quantification of LDL-C (Low density lipoprotein Cholesterol) [Blood]

35

Quantification of Triglycerides [Blood]

36

Qualitative drug screening test in urine for one substance

Laboratory testing using substances

37

Drug screening and qualitative testing for five types of drugs

38

Rapid opiate detection test in urine, or Qualitative Opiate (rapid test) [urine]

39

Rapid drug detection test in urine

40

Qualitative Amphetamine (rapid test) [urine]

41

Qualitative Marijuana (THC) (rapid test) [urine]

42

Qualitative Morphine (rapid test) [urine]

43

Qualitative Codeine (rapid test) [urine]

44

Qualitative Heroin (rapid test) [urine]

45

Methamphetamine (rapid test)

46

Cocaine urine (rapid test)

47

Chest X-ray

Imaging and functional laboratory tests

48

Standard electrocardiogram

49

Abdominal ultrasound (liver, gallbladder, pancreas, spleen, kidneys, bladder)

50

Computed tomography of the brain

51

Electroencephalogram (computerized or video)

52

Cerebral blood flow measurement

53

Psychological assessment

Psychological laboratory testing

54

Collection, preservation, and transportation of blood specimens (blood, serum, plasma, etc.) for serological testing

Specimen collection, preservation, and transportation

55

Collection, preservation, and transportation of dried blood spot specimens

56

Collection, preservation, and transportation of blood specimens (blood, serum, plasma, etc.) for molecular biology testing

57

Production and supply of internal quality control serological HIV sample kits

Supply of internal quality control samples on serum to evaluate the quality of testing through the production and distribution of sample kits for laboratories to perform, ensuring the quality of testing when providing services

58

Production and supply of internal quality control CD4 cell count sample kits

59

Production and supply of internal quality control serological HIV-HBsAg-HCV-Syphilis sample kits

60

Production and supply of external quality control program, sample sets for evaluating laboratory capacity in serological HIV testing

Supply of external quality control serological samples on serum to evaluate the quality of testing for HIV/AIDS prevention and control through the production and distribution of sample sets and analysis and evaluation of results from participating units

61

Production and supply of external quality control program for CD4 cell count testing

62

Production and supply of external quality control serological HIV-HBsAg-HCV-Syphilis program